<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03942757</url>
  </required_header>
  <id_info>
    <org_study_id>PI2018_843_0021</org_study_id>
    <nct_id>NCT03942757</nct_id>
  </id_info>
  <brief_title>BiLirubin Decrease Under Phototherapy Exposure in the Preterm Newborn in Incubator</brief_title>
  <acronym>BLUE</acronym>
  <official_title>BiLirubin Decrease Under Phototherapy Exposure in the Preterm Newborn in Incubator</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Phototherapy is routinely used in neonatal intensive care units for the treatment of
      jaundice. Guidelines focus mainly on bilirubin serum levels to start the phototherapy. Only
      few data are available about clinical management of phototherapy devices and subsequently the
      impact on bilirubin serum decrease. Especially there are no strong recommendations about
      phototherapy duration, irradiance measurements, incubator temperature and humidity settings.
      Various factors can influence irradiance and thus the preterm infant bilirubin serum
      decrease. This study aims at evaluating the impact of an educational program on the use and
      efficacy of phototherapy in a neonatal intensive care unit.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Only few data are available about clinical management of phototherapy devices for the
      treatment of jaundice in the preterm infant.

      This study is a prospective, monocentric, observational study. Preterm infant &lt; 35 weeks of
      gestation with a jaundice requiring phototherapy according to NICE guidelines can be included
      for the duration of the phototherapy treatment.

      The decrease in bilirubin serum level before and after phototherapy treatment will be
      measured.

      This decrease in bilirubin serum level will be assessed for two consecutive periods before
      and after an educational program on jaundice management of the preterm infant.

      The investigators aim at demonstrating that an educational program could improve phototherapy
      management and result in a higher decrease in bilirubin serum during treatment of the preterm
      infant with jaundice.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 2, 2019</start_date>
  <completion_date type="Actual">March 19, 2020</completion_date>
  <primary_completion_date type="Actual">March 19, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Day</target_duration>
  <primary_outcome>
    <measure>Change in bilirubin serum level (μmol/L/h)</measure>
    <time_frame>before and 24 hours after start of phototherapy treatment</time_frame>
    <description>Change in bilirubin serum level (μmol/L/h) = (end bilirubin (μmol/L) - start bilirubin (μmol/L)) / delay between the 2 measurements (h)</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">200</enrollment>
  <condition>Preterm Infant</condition>
  <condition>Jaundice, Neonatal</condition>
  <condition>Phototherapy</condition>
  <arm_group>
    <arm_group_label>observation before educational program</arm_group_label>
    <description>100 preterm infant medical records will be studied in a first part of this observational study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Observation after educational program</arm_group_label>
    <description>An educational program will be implemented in the unit after this first period. 100 preterm infant will be included in a second part of this observational study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>bilirubin serum level determination</intervention_name>
    <description>bilirubin serum level before and after phototherapy treatment will be measured</description>
    <arm_group_label>Observation after educational program</arm_group_label>
    <arm_group_label>observation before educational program</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Phototherapy</intervention_name>
    <description>Preterm infant &lt; 35 weeks of gestation with a jaundice requiring phototherapy according to NICE guidelines can be included for the duration of the phototherapy treatment.</description>
    <arm_group_label>Observation after educational program</arm_group_label>
    <arm_group_label>observation before educational program</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      serum
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Prospective, monocentric, observational study. All the preterm infant with a jaundice
        requiring a treatment with phototherapy could been screened for eligibility criteria
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  preterm infant less than 35 weeks gestation

          -  preterm infant hospitalized in the neonatal intensive care unit of CHU Amiens-Picardie

          -  preterm infant placed in an incubator

          -  preterm infant with a jaundice requiring treatment according to NICE guidelines

          -  preterm infant with a no hemolytic disease

          -  preterm infant with informed written consent from the parents

        Exclusion Criteria:

          -  preterm infant more than 35 weeks of gestation

          -  preterm infant with hemolytic disease

          -  preterm infant with Jaundice related to a cholestasis

          -  Jaundice requiring exchange transfusion
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Day</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80480</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>May 2, 2019</study_first_submitted>
  <study_first_submitted_qc>May 7, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2019</study_first_posted>
  <last_update_submitted>March 20, 2020</last_update_submitted>
  <last_update_submitted_qc>March 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>preterm infant</keyword>
  <keyword>jaundice</keyword>
  <keyword>bilirubin</keyword>
  <keyword>phototherapy</keyword>
  <keyword>educational program</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Premature Birth</mesh_term>
    <mesh_term>Jaundice, Neonatal</mesh_term>
    <mesh_term>Jaundice</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bilirubin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

